Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A common cough syrup, Ambroxol, has shown potential in slowing the progression of Parkinson's dementia in a recent clinical trial.

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Common cough medicine revealed to slow down Parkinson's disease and dementia - A 12-month study found that Ambroxol helped ...

Common cough medicine could slow dementia in Parkinson’s patients, study hints Cough medicine widely used in Europe remains unapproved for use in US, Canada, researchers say Vishwam Sankaran ...

Researchers at Lawson Research Institute are studying Ambroxol - a common cough medicine in Europe - as a potential treatment for dementia linked to Parkinson’s disease LONDON, Ont. – Dementia ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...